This study focuses on labor induction in pregnant women who have an unfavorable cervix after initial cervical ripening treatment. The research compares two different approaches to inducing labor: using oxytocin versus continuing with prostaglandins. The purpose is to determine if using oxytocin is as effective as prostaglandins for labor induction after the first 24 hours of cervical preparation.
The medications being studied include Oxytocine Panpharma, which is given through an intravenous injection, and several prostaglandin preparations: Propess (vaginal delivery system), Prostine E2 (vaginal gel), and Angusta (oral tablet). These medications are commonly used to help start and progress labor in pregnant women whose cervix is not yet ready for delivery.
During the study, women will receive either oxytocin through an IV or one of the prostaglandin medications after their initial cervical ripening treatment has been completed. The study will track various outcomes related to the delivery process and the health of both mother and baby, with special attention to the rate of cesarean delivery. The research will also evaluate factors such as the time until delivery and any complications that may occur during the process.
France 